EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease

Manoj Bisht, Jai Parkash Kadian, Tanuj Hooda, Neelam Jain, Amit Lather, Navidha Aggarwal

Drug Research · 01.10.2024 · 74 (08) · 365-378

DOI: 10.1055/a-2401-4578 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Research, erschienen am 01.10.2024. Verfasst von Manoj Bisht und 5 weiteren Autor:innen. Beteiligte Einrichtung: Devasthali Vidyapeeth College of Pharmacy, Rudrapur, Uttarakhand, India. Hauptthemen laut MEDLINE: Parkinson Disease, Lysophospholipids, Sphingosine, Signal Transduction. Die Arbeit nennt 98 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sphingosine-1-phosphate (S1P) is a cellular signalling molecule derived from sphingosine, which is a pro-apoptotic sphingolipid. Sphingolipids control various cellular actions like growth, homeostasis, and stress-related responses. The main sources of S1P in our body are erythrocytes. S1P controls both cellular mediators and other second messengers intracellularly. The S1P receptor also helps in inflammatory and neuroprotective effects (required to manage of Parkinsonʼs). A large number of anti-Parkinson drugs are available, but still, there is a need for more effective and safer drugs. S1P and its receptors could be targeted as novel drugs due to their involvement in neuro-inflammation and Parkinsonʼs. The present review effort to explore the biological role of S1P and related receptors, for their possible involvement in PD; furthermore. Overall, S1P and other related metabolizing enzymes have significant therapeutic opportunities for Parkinsonʼs disease along with other neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseLysophospholipidsSphingosineSignal TransductionHumansAnimalsNeuroprotective AgentsAntiparkinson AgentsSphingosine-1-Phosphate Receptors

Substanzen

Lysophospholipidssphingosine 1-phosphateSphingosineNeuroprotective AgentsAntiparkinson AgentsSphingosine-1-Phosphate Receptors

Autor:innen und Institutionen

  • Devasthali Vidyapeeth College of Pharmacy, Rudrapur, Uttarakhand, India.
  • Adarsh Vijendra Institute of Pharmaceutical Sciences, Shobhit University, Gangoh (Saharanpur)- UP India.
  • MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India.
  • Department of Pharmaceutical Education & Research, Bhagat Phool Singh Mahila Vishwavidyalaya, Khanpur Kalan, Sonepat, Haryana, India.

Zitieren

APA

Bisht, M., Kadian, J. P., Hooda, T., Jain, N., Lather, A., & Aggarwal, N. (2024). Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease. Drug Research, 74(08), 365-378. https://doi.org/10.1055/a-2401-4578

Vancouver

Bisht M, Kadian JP, Hooda T, Jain N, Lather A, Aggarwal N. Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease. Drug Research. 2024;74(08):365-378. doi:10.1055/a-2401-4578

BibTeX
@article{Bisht2024,
  author = {Bisht, Manoj and Kadian, Jai Parkash and Hooda, Tanuj and Jain, Neelam and Lather, Amit and Aggarwal, Navidha},
  title = {Explore the Role of the Sphingosine-1-Phosphate Signalling as a Novel Promising Therapeutic Target for the Management of Parkinson's Disease},
  journal = {Drug Research},
  year = {2024},
  volume = {74},
  number = {08},
  pages = {365--378},
  doi = {10.1055/a-2401-4578}
}
Kostenlos starten →